7 Einträge gefunden

1. Heterogeneity and chronology of 6q15 deletion and ERG-fusion in prostate cancer

   1. Kluth, Martina
   2. Meyer, David
   3. Krohn, Antje
   4. Freudenthaler, Fabian
   5. Bauer, Melanie
   6. Salomon, Georg
   7. Heinzer, Hans

   2016 - Forschungsinformationssystem des UKE
2. High c-MET expression is frequent but not associated with early PSA recurrence in prostate cancer.

   1. Jacobsen, Frank
   2. Ashtiani, Sharad Nouraie
   3. Tennstedt, Pierre
   4. Heinzer, Hans
   5. Simon, Ronald
   6. Sauter, Guido
   7. Sirma, Hüseyin

   2013 - Forschungsinformationssystem des UKE
3. SPINK1 expression is tightly linked to 6q15- and 5q21-deleted ERG-fusion negative prostate cancers but unrelated to PSA recurrence

   1. Grupp, Katharina
   2. Diebel, Franz
   3. Sirma, Hüseyin
   4. Simon, Ronald
   5. Breitmeyer, Karin
   6. Steurer, Stefan
   7. Hube-Magg, Claudia

   2013 - Forschungsinformationssystem des UKE
4. Loss of pSer2448-mTOR expression is linked to adverse prognosis and tumor progression in ERG-fusion-positive cancers.

   1. Müller, Juliane
   2. Ehlers, Arne
   3. Burkhardt, Lia
   4. Sirma, Hüseyin
   5. Steuber, Thomas
   6. Graefen, Markus
   7. Sauter, Guido

   2013 - Forschungsinformationssystem des UKE
5. Loss of CDKN1B/p27Kip1 expression is associated with ERG fusion-negative prostate cancer, but is unrelated to patient prognosis

   1. Sirma, Hüseyin
   2. Broemel, Margarethe
   3. Stumm, Laura
   4. Tsourlakis, Maria Christina
   5. Steurer, Stefan
   6. Tennstedt, Pierre
   7. Salomon, Georg

   2013 - Forschungsinformationssystem des UKE
6. Reduced CD147 expression is linked to ERG fusion-positive prostate cancers but lacks substantial impact on PSA recurrence in patients treated by radical prostatectomy

   1. Grupp, Katharina
   2. Höhne, Thorsten Simon
   3. Prien, Kristina
   4. Hube-Magg, Claudia
   5. Tsourlakis, Maria Christina
   6. Sirma, Hüseyin
   7. Pham, Taher

   2013 - Forschungsinformationssystem des UKE
7. Strong expression of the neuronal transcription factor FOXP2 is linked to an increased risk of early PSA recurrence in ERG fusion-negative cancers.

   1. Stumm, Laura
   2. Burkhardt, Lia
   3. Steurer, Stefan
   4. Simon, Ronald
   5. Adam, Meike
   6. Becker, Andreas
   7. Sauter, Guido

   2013 - Forschungsinformationssystem des UKE